{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/prostatitis-chronic/diagnosis/investigations/","result":{"pageContext":{"chapter":{"id":"07fe1726-43db-50e8-854d-9e8d2048398c","slug":"investigations","fullItemName":"Investigations","depth":2,"htmlHeader":"<!-- begin field 0b26d8ae-c2c0-4336-8d0b-1408c4ad7300 --><h2>What investigations should I do?</h2><!-- end field 0b26d8ae-c2c0-4336-8d0b-1408c4ad7300 -->","summary":"","htmlStringContent":"<!-- begin item 9c5af528-d32d-49eb-9999-878f4b1e1c35 --><!-- begin field b98ff047-f658-49fa-885b-03246fe6f38d --><ul><li><strong>Dipstick the urine to check for blood, glucose, protein, leucocytes, and nitrite, and</strong> <strong>c</strong><strong>ollect a mid-stream specimen of urine (MSU) to send for culture and sensitivity to confirm or exclude the presence of a urinary tract infection. </strong>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a>. <ul><li>A positive urine culture indicates the presence of chronic bacterial prostatitis, however unless an acute UTI is present an MSU may be normal in men with chronic bacterial prostatitis. Therefore it is advisable to also check previous MSU reports.</li></ul></li><li><strong>Perform a sexually transmitted infection (STI) screen (first pass urine for gonorrhoea/chlamydia NAAT [Nucleic Acid Amplification Test]), and consider sending a urethral swab for trichomoniasis. </strong>Particularly in sexually active men younger than 35 years and men with multiple sexual partners or recent partner change.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>, <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a>.</li></ul></li><li><strong>Consider a prostate specific antigen (PSA) blood test to rule out prostate cancer only after discussing the indications for the test, the interpretation and implications of the result, and considering with the man whether an abnormal result would affect further management choices.</strong><ul><li>Provide sufficient time for the man to decide if he wishes to have the test.</li><li>For more information, see the <a class=\"topic-reference external-reference\" href=\"/topics/luts-in-men/diagnosis/investigations/\">Investigations</a> section in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/luts-in-men/\">LUTS in men</a>, and the section on <a class=\"topic-reference external-reference\" href=\"/topics/prostate-cancer/diagnosis/psa-testing/\">PSA testing</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/prostate-cancer/\">Prostate cancer</a>.  </li></ul></li><li><strong>Assess renal function by measuring serum creatinine and estimated glomerular filtration rate (eGFR) if clinically indicated, for example if the man has:</strong><ul><li>Recurrent urinary tract infection.</li><li>Chronic urinary retention.</li><li>A history of renal stones.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a> and <a class=\"topic-reference external-reference\" href=\"/topics/acute-kidney-injury/\">Acute kidney injury</a>.</li></ul></li></ul></li></ul><!-- end field b98ff047-f658-49fa-885b-03246fe6f38d --><!-- end item 9c5af528-d32d-49eb-9999-878f4b1e1c35 -->","topic":{"id":"c4c9527b-558e-5f8e-bc17-8e290dcde258","topicId":"e7c47213-5bd0-4104-8047-fdc108a48fed","topicName":"Prostatitis - chronic","slug":"prostatitis-chronic","lastRevised":"Last revised in September 2019","chapters":[{"id":"db8b7f60-5def-5da6-8f5a-97b134fe81af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"261b0e99-ad07-59aa-82ad-fa8c5e297c03","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"191f6daf-33c8-5a36-9298-deb70f2118f9","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3196f07a-652b-594b-a01b-c5adf6819612","slug":"changes","fullItemName":"Changes"},{"id":"cb3c96a5-276d-5602-88a2-6fe23e9db68a","slug":"update","fullItemName":"Update"}]},{"id":"71da42c9-a078-59ae-90c6-752133b53212","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"aec7f6cf-32f0-5cb8-997e-4fef498eea4a","slug":"goals","fullItemName":"Goals"},{"id":"3afbaae7-ae1e-5df4-87a4-e8fcadd24ce9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"87d31fcb-2e1a-5f5f-b2b3-3cebf26dbf5e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b0e77d09-ef7a-52ce-a61d-d74872fcd77f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"73212593-e3d8-52ec-9384-1ee26a9e0290","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"59aaca07-0adb-5035-afea-fd747f067bc8","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"864060e0-9a10-5069-9b80-daf6551f49b4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"120b86df-be4c-54e8-ab8a-7edcad60de73","slug":"definition","fullItemName":"Definition"},{"id":"a35c2de7-75f2-59f4-9df6-6115e92ac1f7","slug":"causes","fullItemName":"Causes"},{"id":"3aa8e065-e5d9-587b-92fa-8e1824a53f6e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"34308471-71dc-5ccd-bf18-de90bce09174","slug":"prognosis","fullItemName":"Prognosis"},{"id":"6bcf89d2-7be0-5893-bcef-296b2b00b23e","slug":"complications","fullItemName":"Complications"}]},{"id":"e0b8b43d-8013-564a-b64b-23866b939127","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"5803967f-79d1-596c-8fb4-58eb0581f053","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"2901399a-1d1a-5b5e-ba74-a8e2973308cc","slug":"assessment","fullItemName":"Assessment"},{"id":"07fe1726-43db-50e8-854d-9e8d2048398c","slug":"investigations","fullItemName":"Investigations"},{"id":"3cf83ed6-63bf-58b4-97f7-98cd7d6815da","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"dc9db115-7acf-5a8a-9dd1-f6bf8dd93454","fullItemName":"Management","slug":"management","subChapters":[{"id":"dbc1e2eb-5ed6-5e3b-9aa6-6f4a53bae15e","slug":"managing-chronic-prostatitis","fullItemName":"Scenario: Managing chronic prostatitis"}]},{"id":"c609cd7e-5825-5ffb-83e8-ba87b7f7806d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"035b193a-907c-5212-99c7-e8a8926b1594","slug":"paracetamol-ibuprofen-codeine","fullItemName":"Paracetamol, ibuprofen, and codeine"},{"id":"f4e7b4f3-38ad-521e-bb43-4c48ac37724f","slug":"alpha-blockers","fullItemName":"Alpha-blockers"},{"id":"24c19a61-fe65-594c-a4e5-ab3b500281e4","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"2a603a06-dc49-5056-bf3b-1492b6300035","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"39e951b0-a3a9-5bae-8465-8d5b1ac9504b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d8eb1d6d-d3f5-593e-bcbc-4214d26beee2","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a9bd9455-225c-5705-8101-1b4f3177119c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3984c05f-a691-5d06-9587-785be5667206","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e6bedf32-0ef7-5118-b6e2-fc3c2631a8c3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"1405259b-4bc7-5907-af93-234db06e958f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ad44cee6-1d13-5c9e-9587-6de26a5b22fd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"160b464d-6dc9-5bb7-9156-90aa025b130c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e0b8b43d-8013-564a-b64b-23866b939127","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"ba45bbda-c1d6-5623-9a69-95ef0ebf2df1","slug":"basis-for-recommendation-c64","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 01e5edb8-3f8e-4545-8429-4a00731af753 --><h3>Basis for recommendation</h3><!-- end field 01e5edb8-3f8e-4545-8429-4a00731af753 -->","summary":null,"htmlStringContent":"<!-- begin item c6424ed7-a4a4-4db7-83de-e3cc880be618 --><!-- begin field 1aa5c25d-705b-42d8-958c-87b249cf58b0 --><p>These recommendations are based on expert opinion in the UK consensus guideline <em>Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">Rees et al, 2014</a>], the European Association of Urology (EAU) <em>Guideline on Urological infections </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">EAU, 2019b</a>], the National Institute for Health and Care Excellence (NICE) guideline <em>Lower urinary tract symptoms in men: management</em><em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">NICE, 2015</a>], the (BASHH) guideline <em>Sexually transmitted infections in primary care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">Lazaro, 2013</a>], and expert opinion in a narrative review <em>Common questions about chronic prostatitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">Holt, 2016</a>]. </p><h4>Screening for a sexually transmitted infection</h4><ul><li>CKS acknowledges that sexually transmitted infections are a rare cause of chronic prostatitis. The recommendation to screen for chlamydia and gonorrhoea is based on expert opinion from a UK consensus guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">Rees et al, 2014</a>] and a BASHH guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">Lazaro, 2013</a>]. Expert opinion from reviewers of the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/prostatitis-acute/\">Prostatitis - acute</a> has guided which particular groups of men to consider for testing.</li><li>The recommendation to consider sending a urethral swab to test for trichomoniasis is based on what CKS considers to be good clinical practice as prostatitis is a rare complication of trichomoniasis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/prostatitis-chronic/references/\">BASHH, 2014</a>].</li></ul><h4>Assessing renal function</h4><ul><li>The recommendation to assess renal function has been extrapolated from recommendations in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/luts-in-men/\">LUTS in men</a> topic.</li></ul><!-- end field 1aa5c25d-705b-42d8-958c-87b249cf58b0 --><!-- end item c6424ed7-a4a4-4db7-83de-e3cc880be618 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}